Christoph Lรผtge retweeted
๐บ Watch IEAI Director Christoph Lรผtge's Q&A with the alignAI Doctoral Network: youtu.be/GqEAVFzJrpE
#alignAI #IEAI #TUM #MSCA #HorizonEurope #DoctoralNetworks #TRAIF2026
2
3
202
Jun 15
A 3D-printing company turning into a healthcare AI company. Whose playbook this is, and it is the $TEM AI playbook, brought by one of $TEM 's own early backers.
$NNDM signed a non-binding term sheet to combine with Infinite Epigenetics, an AI-powered preventive health and diagnostics company, at an $890 million transaction value. The combined business would trade on Nasdaq under the proposed ticker $IEAI. Infinite is built on two real revenue-generating units, the CLIA lab TruDiagnostic and the longevity brand Tally Health, with more than 120,000 epigenetic samples collected since 2020 and a proprietary DNA methylation dataset aimed at a $90 billion plus US diagnostics market.
Infinite was co-founded by Brad Keywell, an original investor and board member of $TEM AI and Eric Lefkofsky's longtime partner from the Groupon and Lightbank years. $NNDM 's own deck names the template in plain sight: Exact Sciences ($EXAS) proved molecular diagnostics can scale in public markets, GRAIL ($GRAL) validated methylation testing from blood, and $TEM proved that proprietary clinical data plus AI can create a brand new category in precision medicine.
Keywell put the thesis directly. Brad Keywell, co-founder of Infinite Epigenetics and an original investor and board member of $TEM , said: "We believe the most valuable healthcare AI platforms will be built on proprietary biological data, leveraging AI for novel discoveries and insights."
That sentence is the entire Tempus model. $TEM came public in June 2024 at $37 a share and built a moat out of data no one else had, more than 500 petabytes across more than 2,000 healthcare institutions, where every new case made the AI better. Infinite is betting the same logic holds one layer deeper, on the epigenome, where each test feeds the model and the model sharpens the next test.
The catch is that pedigree is not a product and a term sheet is not a deal. This is non-binding, with a 30-day exclusivity window and no definitive agreement signed yet. The open question is whether methylation data proves as defensible and as monetizable as the multimodal oncology data $TEM Tempus assembled, and whether reverse-merging into a cash shell is as clean a path as $TEM 's own IPO was.
For existing $NNDM holders, the term sheet values their stock at a 20 percent premium to estimated net cash and leaves them a minority slice of a company expected to hold over $400 million in cash at closing, plus a contingent value right on the legacy assets. They are swapping a shrinking manufacturing business for a call option on the $TEM playbook run back in epigenetics.
Would you rather own the proven version in $TEM or the team trying to rebuild it?
It's not a sprint, it's a marathon.
Jun 9
This $TEM study looks like a dry science paper, but it shows where the edge in AI medicine actually sits.
The tech in short. Exome testing reads the part of your DNA that codes for proteins, where most disease mutations hide. The problem is it often returns a variant of uncertain significance, a spelling change you cannot judge from DNA alone. RNA fixes that. If DNA is the instruction manual, RNA is it being read out loud, so it shows directly when a mutation breaks how a gene is spliced. Ambry, now owned by $TEM, runs RNA on top of the DNA exome to turn an uncertain result into a clear one.
The proof: nearly 2,000 variants over five years, about one in ten splicing related, and most in genes you can confirm from a simple blood draw. RNA also helped non white patients more, where the databases are thinner.
My take. This is not a revenue event, it is a data event. $TEM is a data company first, and almost no one else runs paired DNA and RNA at this scale. That is the quiet edge. The catch is it still has to turn that lead into profit, and diagnostics lives on reimbursement.
Validation, not a catalyst.
Do you value $TEM more for the AI or the data underneath it?
It's not a sprint, it's a marathon.
1
2
9
1,205
Jun 15
Nano Dimension signs non-binding term sheet to merge with Infinite Epigenetics, valuing Infinite at $890M. The combined company would trade as IEAI on Nasdaq, with over $400M cash at closing. Infinite owns TruDiagnostic and Tally Health, 120K samples, AI-powered diagnostics foโฆ
1
56
Jun 15
Nano Dimension $NNDM signed a non-binding term sheet to merge with Infinite Epigenetics in a deal valuing Infinite at $890M.
The combined company would operate as Infinite Epigenetics and trade on Nasdaq under $IEAI, with over $400M in expected cash at closing.
Infinite owns TruDiagnostic and Tally Health, has collected 120K epigenetic samples since 2020, and focuses on AI-powered diagnostics for chronic diseases including cardiovascular disease, Type 2 diabetes, COPD, and MASLD.
5
2
31
11,113
Jun 15
$NNDM Nano Dimension merging with Infinite Epigenetics โ pivoting its Nasdaq listing and cash into AI-powered epigenetics diagnostics.
Infinite owns TruDiagnostic (120K samples, CLIA lab) and Tally Health. $890M transaction value. Combined company keeps $400M cash, no dilution needed.
Ticker becomes $IEAI. Term sheet only โ 30-day exclusivity running now.
Not financial advice.
1
473
Following its premiere during @TRAIF2026 @amerikahaus, the #MoralPLaixDocumentary is released online1 Watch it reflect on its themes and join the ongoing conversation! #LLMs #Chatbots #AI #AIEthics #MoralPLai #IEAI
ieai.sot.tum.de/moralplai-reโฆ
53
Last week, guest lecturer, Prof. Thomas Maak held a talk entitled: ๐๐ฆ๐ด๐ฑ๐ฐ๐ฏ๐ด๐ช๐ฃ๐ญ๐ฆ ๐๐ฆ๐ข๐ฅ๐ฆ๐ณ๐ด๐ฉ๐ช๐ฑ ๐ฐ๐ง #๐๐ณ๐ต๐ช๐ง๐ช๐ค๐ช๐ข๐ญ๐๐ฏ๐ต๐ฆ๐ญ๐ญ๐ช๐จ๐ฆ๐ฏ๐ค๐ฆ at the course #EthicsofAI held by Prof. Christoph Lรผtge. We thank Thomas for his insightful talk!
#TRAIF2026 #IEAI
1
2
48
It's time for good gestures in this invasion. The US blockade has hurt us immensely, plus the world. Let's kill two birds with one stone. Let's give the world an opened Strait in exchange for IEAI inspectors into Iran to see what the poop is on their nuke ambitions. Gestures.
2
3
35
It's time for good gestures in this invasion. The US blockade has hurt us immensely, plus the world. Let's kill two birds with one stone. Let's give the world an opened Strait in exchange for IEAI inspectors into Iran to see what the poop is on their nuke ambitions. Gestures.
1
1
1
24
#TRAIF2026 ๐ฃ๐ฎ๐ป๐ฒ๐น ๐ข๐ป ๐๐ ๐๐ป๐ฑ ๐๐ฑ๐๐ฐ๐ฎ๐๐ถ๐ผ๐ป
Moderated by Prof. Nicole Lรธnfeldt, panelists: Prof. Christiane Lรผtge, Prof. Anna Keune & Prof. Sneha Das.
๐บ&๐ฐ: bit.ly/4uBC2ww
@amerikahaus @TU_Muenchen
#IEAI #TUM #MSCA #DoctoralNetworks #HorizonEurope
2
4
323
๐ฃ #IEAI #SpeakerSeries with Christopher Cowton
โ#๐๐๐๐ต๐ฉ๐ช๐ค๐ด ๐ข๐ต ๐๐ฐ๐ณ๐ฌ: ๐๐ฆ๐ง๐ญ๐ฆ๐ค๐ต๐ช๐ฐ๐ฏ๐ด ๐ฐ๐ฏ ๐๐ฆ๐ด๐ช๐จ๐ฏ๐ช๐ฏ๐จ ๐๐ณ๐ข๐ช๐ฏ๐ช๐ฏ๐จ ๐ง๐ฐ๐ณ ๐๐ค๐ค๐ฐ๐ถ๐ฏ๐ต๐ข๐ฏ๐ต๐ดโ
๐
June 24
๐ 12:00โ1:00PM
๐ TUMThinkTank
๐ bit.ly/4fsYuUB
We look forward to welcoming you!
2
4
370
How about a end to the blockade, relief the Strait. In Exchange, Iran will gladly allow IEAI inspectors in to quantify the Uranium they have. This would be a positive implantation, too bad our idiot is stuck not knowing what to do, surrounding by Dumbfucks. #VoteBlue2026
1
4
46
"Tentative Deal" with Iran if Trump goes for it. It's about as real as my third eye. I bet he'll rely on the old "Iran will have no nuclear weapons". This is the main sticking point when we don't even know for sure how much enriched Uranium unless IEAI inspectors get in.
3
4
52
I awaken to the news that the US and Iran exchanged strikes, more craziness on top of craziness. I don't want the invasion to continue, I want an exchange of a different sort. It's all about gestures at this time, instead of bombing, undo the blockade, add IEAI inspectors.
2
3
86
TYVM for your answer. Recall when we Bombed Iran's nuke facilities back in June, then we bomb nuke sites on Feb 28? Seems they probably have some, but how much? I don't trust the Mossad, nor Netanyahu. Maybe if we bug the Hell out of them to put IEAI in there, all bets are off.โค๏ธ
1
4
44
Perfect definition Meg, Good meme. I have a question for you...We are getting ripped off not having IEAI Inspectors in Iran. How is one to determine the severity if we don't even know the data? Sure we have old data, we need fresh data. โฎ๏ธโค๏ธ๐ซ๐ซ๐ฏ๐ฏ๐๐
1
4
46